ANKTIVA THE NK CELL GROWTH FACTOR Trademark
Trademark Overview
On Wednesday, December 3, 2025, a trademark application was filed for ANKTIVA THE NK CELL GROWTH FACTOR with the United States Patent and Trademark Office. The USPTO has given the ANKTIVA THE NK CELL GROWTH FACTOR trademark a serial number of 99527269. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 25, 2026. This trademark is owned by ImmunityBio, Inc.. The ANKTIVA THE NK CELL GROWTH FACTOR trademark is filed in the Pharmaceutical Products category with the following description:
Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer; Biological preparations for the prevention and treatment of cancer and infectious diseases; Vaccines
General Information
| Serial Number | 99527269 |
| Word Mark | ANKTIVA THE NK CELL GROWTH FACTOR |
| Filing Date | Wednesday, December 3, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, June 25, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 14, 2026 |
Trademark Statements
| Goods and Services | Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer; Biological preparations for the prevention and treatment of cancer and infectious diseases; Vaccines |
| Pseudo Mark | ANKTIVA THE NATURAL KILLER CELL GROWTH FACTOR |
| NOT AVAILABLE | "THE NK CELL GROWTH FACTOR" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 3, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ImmunityBio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 3, 2025 | NEW APPLICATION ENTERED |
| Wednesday, December 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 13, 2026 | ASSIGNED TO EXAMINER |
| Monday, March 16, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, March 16, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, March 16, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 16, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 16, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 16, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 18, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
